Eagle Asset Management Inc Biomarin Pharmaceutical Inc Transaction History

Eagle Asset Management Inc

$16.7 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$74.43 - $92.22 $2.71 Million - $3.36 Million	-36,393 Reduced 5.11%	676,136 $55.7 Million
Q1 2024 May 09, 2024	BUY	$83.81 - $99.0 $23.2 Million - $27.3 Million	276,250 Added 63.32%	712,529 $62.2 Million
Q4 2023 Feb 12, 2024	SELL	$76.22 - $98.51 $138,110 - $178,500	-1,812 Reduced 0.41%	436,279 $42.1 Million
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $1,616 - $1,795	-19 Reduced -0.0%	438,091 $38.8 Million
Q2 2023 Aug 09, 2023	BUY	$86.68 - $100.3 $38 Million - $43.9 Million	438,110 New	438,110 $38 Million
Q2 2021 Aug 11, 2021	SELL	$75.51 - $84.79 $42.6 Million - $47.9 Million	-564,702 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $2.34 Million - $2.84 Million	31,326 Added 5.87%	564,702 $44 Million
Q4 2020 Feb 12, 2021	SELL	$72.61 - $90.2 $3.15 Million - $3.91 Million	-43,340 Reduced 7.51%	533,376 $46.8 Million
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $149,705 - $272,935	-2,083 Reduced 0.36%	576,716 $43.8 Million
Q2 2020 Aug 12, 2020	BUY	$79.55 - $124.22 $12.2 Million - $19.1 Million	153,457 Added 36.08%	578,799 $70.7 Million
Q1 2020 May 11, 2020	BUY	$71.37 - $96.85 $30.4 Million - $41.2 Million	425,342 New	425,342 $35.9 Million
Q2 2018 Aug 07, 2018	SELL	$76.01 - $99.03 $30.3 Million - $39.5 Million	-398,436 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$77.67 - $92.63 $1.98 Million - $2.36 Million	25,459 Added 6.83%	398,436 $32.3 Million
Q4 2017 Feb 09, 2018	BUY	$80.76 - $95.13 $4.27 Million - $5.03 Million	52,913 Added 16.53%	372,977 $33.2 Million
Q3 2017 Nov 09, 2017	BUY	$80.6 - $94.95 $25.8 Million - $30.4 Million	320,064	320,064 $30 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account